[Combination of uterine adenomyosis with leiomyoma].

Arkhiv patologii · 2005 · vol. 67(3) , pp. 31–4 · PMID:16075610 · W2993436497
article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-09

This study morphologically analyzed adenomyosis (AM) and AM with leiomyoma (LM), finding asynchronous receptor expression in AM cells and correlating steroid hormone receptor expression in AM and LM, suggesting a common pathogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A morphological analysis of 50 cases of adenomyosis (AM) and 150 cases of AM combination with leiomyoma (LM) with regard to their morphofunctional and histotopographical interrelations was performed. The asynchronous character and mosaicism of estrogen/progesteron receptors expression in the gland epithelium and AM stromal cells of one patient was established immunohistochemically. This probably determines uneffective hormonal therapy of AM patients. A correlation of steroid hormone receptor expression in AM foci and in leiomyocytes of perifocal myometrium hyperplasia was also found. This indicates a common pathogenic mechanism of AM and LM. An increase of the size of the uterus depended on the degree of perifocal leiomyocyte hyperplasia with microscopical nodule formation in LM.

My notes (saved in your browser only)

Condition tags

mesh:D004715adenomyosis

MeSH descriptors

Endometriosis Leiomyoma Uterine Neoplasms Adult Diagnosis, Differential Endometriosis Endometriosis Endometriosis Female Hormones Hormones Humans Leiomyoma Leiomyoma Leiomyoma Middle Aged Receptors, Steroid Receptors, Steroid Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Cited by (2)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:35.797702+00:00
License: CC0 · commercial use OK